Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Caffeine in Preterm Neonates
NCT03086473Phase 4Unknown
- Start
- Feb 2017
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of caffeine in apnea of prematurity (AOP). Primary endpoint: Incidence of Intubation at 12 hours. Status: unknown.
02
Drugs
caffeine
03
Conditions
apnea of prematurity (AOP)
Beyond the preview
Go deeper on NCT03086473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03086473.